HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Phase II clinical study of Yoshi 864 in squamous cell carcinoma of the uterine cervix.

AuthorsM Slavik, H Muss, J A Blessing
JournalCancer treatment reports (Cancer Treat Rep) Vol. 67 Issue 2 Pg. 195-6 (Feb 1983) ISSN: 0361-5960 [Print] United States
PMID6297730 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Antineoplastic Agents
  • Mesylates
  • improsan
Topics
  • Adult
  • Aged
  • Antineoplastic Agents (administration & dosage, therapeutic use)
  • Carcinoma, Squamous Cell (drug therapy)
  • Drug Evaluation
  • Female
  • Humans
  • Mesylates (administration & dosage, therapeutic use)
  • Middle Aged
  • Uterine Cervical Neoplasms (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: